Statistical breathing curve sampling to quantify interplay effects of moving lung tumors in a 4D Monte Carlo dose calculation framework.
Autor: | von Münchow A; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Straub K; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Losert C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Shpani R; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Hofmaier J; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Freislederer P; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Heinz C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Thieke C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Söhn M; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Alber M; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany., Floca R; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Division of Medical Image Computing, German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany., Belka C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Munich, Germany; Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Germany., Parodi K; Department of Experimental Physics - Medical Physics, Faculty of Physics, LMU Munich, Munich, Germany., Reiner M; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Kamp F; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany. Electronic address: florian.kamp@uk-koeln.de. |
---|---|
Jazyk: | angličtina |
Zdroj: | Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) [Phys Med] 2022 Sep; Vol. 101, pp. 104-111. Date of Electronic Publication: 2022 Aug 18. |
DOI: | 10.1016/j.ejmp.2022.07.006 |
Abstrakt: | Purpose: The interplay between respiratory tumor motion and dose application by intensity modulated radiotherapy (IMRT) techniques can potentially lead to undesirable and non-intuitive deviations from the planned dose distribution. We developed a 4D Monte Carlo (MC) dose recalculation framework featuring statistical breathing curve sampling, to precisely simulate the dose distribution for moving target volumes aiming at a comprehensive assessment of interplay effects. Methods: We implemented a dose accumulation tool that enables dose recalculations of arbitrary breathing curves including the actual breathing curve of the patient. This MC dose recalculation framework is based on linac log-files, facilitating a high temporal resolution up to 0.1 s. By statistical analysis of 128 different breathing curves, interplay susceptibility of different treatment parameters was evaluated for an exemplary patient case. To facilitate prospective clinical application in the treatment planning stage, in which patient breathing curves or linac log-files are not available, we derived a log-file free version with breathing curves generated by a random walk approach. Interplay was quantified by standard deviations σ in D Results: Interplay induced dose deviations for single fractions were observed and evaluated for IMRT and volumetric arc therapy (σ Conclusion: It is feasible to combine statistically sampled breathing curves with MC dose calculations. The universality of the presented framework allows comprehensive assessment of interplay effects in retrospective and prospective clinically relevant scenarios. Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2022 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |